Taki Chemical Past Earnings Performance
Past criteria checks 1/6
Taki Chemical has been growing earnings at an average annual rate of 3%, while the Chemicals industry saw earnings growing at 6.5% annually. Revenues have been growing at an average rate of 2.5% per year. Taki Chemical's return on equity is 4.1%, and it has net margins of 4.1%.
Key information
3.0%
Earnings growth rate
3.0%
EPS growth rate
Chemicals Industry Growth | 6.6% |
Revenue growth rate | 2.5% |
Return on equity | 4.1% |
Net Margin | 4.1% |
Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Taki Chemical makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Mar 24 | 35,288 | 1,463 | 5,442 | 486 |
31 Dec 23 | 34,852 | 1,356 | 5,372 | 486 |
30 Sep 23 | 35,433 | 1,088 | 5,363 | 497 |
30 Jun 23 | 35,302 | 1,292 | 5,355 | 497 |
31 Mar 23 | 36,277 | 1,870 | 5,404 | 497 |
31 Dec 22 | 35,846 | 2,056 | 5,403 | 497 |
30 Sep 22 | 34,875 | 2,163 | 5,563 | 461 |
30 Jun 22 | 34,735 | 2,216 | 5,487 | 461 |
31 Mar 22 | 33,499 | 2,048 | 5,392 | 461 |
31 Dec 21 | 32,812 | 1,916 | 5,353 | 461 |
30 Sep 21 | 31,994 | 2,000 | 5,333 | 421 |
30 Jun 21 | 31,169 | 1,703 | 5,308 | 421 |
31 Mar 21 | 30,249 | 1,500 | 5,284 | 421 |
31 Dec 20 | 30,175 | 1,559 | 5,260 | 421 |
30 Sep 20 | 30,276 | 1,318 | 5,312 | 437 |
30 Jun 20 | 31,401 | 1,462 | 5,372 | 437 |
31 Mar 20 | 32,553 | 1,484 | 5,440 | 437 |
31 Dec 19 | 32,669 | 1,361 | 5,489 | 437 |
30 Sep 19 | 33,338 | 1,458 | 5,534 | 387 |
30 Jun 19 | 33,037 | 1,332 | 5,547 | 387 |
31 Mar 19 | 33,113 | 1,386 | 5,550 | 387 |
31 Dec 18 | 33,089 | 1,743 | 5,527 | 387 |
30 Sep 18 | 32,215 | 1,698 | 5,541 | 383 |
30 Jun 18 | 31,772 | 1,920 | 5,448 | 383 |
31 Mar 18 | 31,757 | 2,056 | 5,425 | 383 |
31 Dec 17 | 32,189 | 1,904 | 5,392 | 383 |
30 Sep 17 | 32,268 | 1,798 | 5,317 | 374 |
30 Jun 17 | 32,847 | 1,642 | 5,346 | 374 |
31 Mar 17 | 32,476 | 1,419 | 5,263 | 374 |
31 Dec 16 | 32,426 | 1,048 | 5,284 | 374 |
30 Sep 16 | 32,946 | 1,014 | 5,246 | 382 |
30 Jun 16 | 32,869 | 963 | 5,257 | 382 |
31 Mar 16 | 33,316 | 1,006 | 5,268 | 382 |
31 Dec 15 | 33,614 | 1,321 | 5,242 | 382 |
30 Sep 15 | 33,804 | 1,479 | 5,275 | 378 |
30 Jun 15 | 33,869 | 1,482 | 5,293 | 378 |
31 Mar 15 | 32,649 | 1,223 | 5,318 | 378 |
31 Dec 14 | 33,936 | 1,274 | 5,428 | 378 |
30 Sep 14 | 34,041 | 1,173 | 5,470 | 394 |
30 Jun 14 | 34,218 | 1,235 | 5,504 | 394 |
31 Mar 14 | 36,022 | 1,625 | 5,564 | 394 |
31 Dec 13 | 34,131 | 1,420 | 5,450 | 394 |
30 Sep 13 | 33,859 | 1,357 | 5,444 | 421 |
30 Jun 13 | 33,561 | 1,331 | 5,410 | 421 |
Quality Earnings: 4025 has a large one-off gain of ¥406.0M impacting its last 12 months of financial results to 31st March, 2024.
Growing Profit Margin: 4025's current net profit margins (4.1%) are lower than last year (5.2%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 4025's earnings have grown by 3% per year over the past 5 years.
Accelerating Growth: 4025's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: 4025 had negative earnings growth (-21.8%) over the past year, making it difficult to compare to the Chemicals industry average (-0.5%).
Return on Equity
High ROE: 4025's Return on Equity (4.1%) is considered low.